A San Diego-based dentist, Dr. Azadeh “Amy” Khajavi studied full mouth reconstruction at the Las Vegas Institute for Advanced Dentistry. Dr. Azadeh Amy Khajavi has won numerous awards, including the Award of Excellence in Full Mouth Reconstruction on Dental Implants and Master Clinician in Aesthetic Dentistry. She performs multiple procedures, including zirconia implants using a patient's growth factor for bone grafts.
Occurring in multiple classes, growth factors are bioactive proteins that control the physiological activities of cells such as growth, proliferation, and differentiation. When applied externally to tissues, growth factors bind to specific surface receptors of target cells. Growth factors are used for alveolar bone regeneration, which is a process involving the formation of a thickened ridge of bones at the base of the teeth that hold the teeth firmly to the jaw. This process also supports dental implants.
Often, applying growth factors directly to the implant sites shows limited success because these substances generally have short half-lives (some less than two minutes), which limits the time the factors will be active. To address this problem, and ensure continuous effect of the factors in targeted cells, growth factors are delivered through carriers, often some type of synthetic polymer. An ideal carrier must ensure uniform, efficient delivery of the growth factors to target cells within the tissue without spreading the growth factors beyond the graft site.
Occurring in multiple classes, growth factors are bioactive proteins that control the physiological activities of cells such as growth, proliferation, and differentiation. When applied externally to tissues, growth factors bind to specific surface receptors of target cells. Growth factors are used for alveolar bone regeneration, which is a process involving the formation of a thickened ridge of bones at the base of the teeth that hold the teeth firmly to the jaw. This process also supports dental implants.
Often, applying growth factors directly to the implant sites shows limited success because these substances generally have short half-lives (some less than two minutes), which limits the time the factors will be active. To address this problem, and ensure continuous effect of the factors in targeted cells, growth factors are delivered through carriers, often some type of synthetic polymer. An ideal carrier must ensure uniform, efficient delivery of the growth factors to target cells within the tissue without spreading the growth factors beyond the graft site.
